Protection of cancer cells by IL-6 from apoptosis and inflammation, DNA damage, antiproliferative, antimetastatic, and antiangiogenic gains of chemotherapy is considered as a major cause of cytotoxic drugs resistance [69,70,71]. This evidence concerns the gene IL6 and cancer.